Previous 10 | Next 10 |
HOLLYWOOD, CA / ACCESSWIRE / June 10, 2022 / Cancer treatment, metaverse, coping; this week on MoneyTV with Donald Baillargeon MoneyTV is the internationally syndicated television program all about money and what makes it happen, ( http://www.moneytv.net ), featuring informative interviews ...
CLEVELAND, OH / ACCESSWIRE / May 19, 2022 / NovAccess Global Inc. (OTC PINK:XSNX) announced that its Chief Executive Officer Dr. Dwain Irvin is scheduled to participate in the LD Micro Invitational XII Conference on June 7-9, 2022. The conference is being held at the Four Seasons Hotel Westl...
LOS ANGELES, CA / ACCESSWIRE / March 17, 2022 / NovAccess Global Inc. (OTC PINK:XSNX) announced today the closing of a series of transactions which results in the reduction of potential common stock dilution by 97.6% and expansion of the shareholder base. The transactions announced today ar...
CLEVELAND, OH / ACCESSWIRE / February 15, 2022 / NovAccess Global, Inc. (OTC PINK:XSNX) announced that its CEO Dr. Dwain Irvin to attend the BIO (Biotechnology innovation organization) CEO and investor conference in New York, NY, which runs from February 14-17, 2022. The conference is focuse...
CLEVELAND, OH / ACCESSWIRE / December 8, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) welcomes new Chief Financial Officer (CFO), Neil Laird. "I am pleased to welcome Neil Laird to the management team," said Dr. Dwain Irvin, Chief Executive Officer, NovAccess Global. Neil J. Laird is an e...
CLEVELAND, OH / ACCESSWIRE / October 6, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced the expansion of its Advisory Board by adding Dr. Kim Seroogy. Dr. Kim Seroogy is currently Professor of Neurology and Director of The Selma Schottenstein Harris Laboratory for Research in Parkin...
CLEVELAND, OH / ACCESSWIRE / September 15, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced Dr. Dwain Irvin's interview on MoneyTV aired on September 11, 2021. MoneyTV has been in the business for 25 years, reaching 200 million homes in 75 countries. Dr. Dwain Irvin's interview can b...
HOLLYWOOD, CA / ACCESSWIRE / September 10, 2021 / Cancer treatment breakthroughs, self-driving cars, restaurant hypocrisy; this week on MoneyTV with Donald Baillargeon MoneyTV is the internationally syndicated television program all about money and what makes it happen, featuring informat...
CLEVELAND, OH / ACCESSWIRE / July 8, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced it has been invited to present at the Society for Brain Mapping and Therapeutics (SBMT) 18 th World Congress, which runs from July 8-11, 2021. The conference is focused on breaking the boundaries of...
NovAccess Global (XSNX) announces that it has received a "productive response" from the U.S. FDA on its pre-investigational new drug ((IND)) meeting request regarding the development plan for Glioblastoma Multiforme ((GBM)) patients, including the clinical study design and dosing strategy for...
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / May 21, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a pioneering biomedical company developing innovative immunotherapies for brain tumor patients, today announced it has submitted a provisional patent for new intellectual property developed at Cedars-Sinai to advance...
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company ...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...